Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02938780 · ClinicalTrials.gov registry record · NA
Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer Survivors
A NA study of Breast Cancer Female, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 1
- Study location
NCT02938780 is a NA study of Breast Cancer Female that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 310 participants, below the 686-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02938780, a NA study of Breast Cancer Female, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 1
- Study location
Study Summary
Preventing or reducing obesity is one factor that has been hailed as a way to improve quality of life, reduce recurrence, and increase survival rates among breast cancer survivors. An experienced team of multi-disciplinary researchers has developed an innovative and unique approach to encourage enhanced nutrition and exercise behaviors in this population using principles of behavioral economics. In particular, the use of social norms or exemplars has been shown in other applications to be effective, and if successful in this population could be inexpensively scaled up for widespread adoption. The proposed pilot study develops a system of text messages for social/mobile media that will provide ongoing reinforcement of desired behavior in breast cancer survivors. These messages would focus on achieving compliance with the expert-developed nutrition and exercise recommendations of the American Cancer Society. In the main study, 310 breast cancer survivors will be randomly placed in intervention and control groups for the 12 week study. Behavior change will be measured using established measures of self-reported behavior. In a sub-study, 60 of the breast cancer survivor participants will also provide blood and urine samples so changes in biomarkers can be assessed. The impact of the study will be measured by biomarkers and self-reported survey responses.
Conditions Studied
Interventions
- OTHER placebo text message
- OTHER nutrition physical activity text message
Study Locations (1)
Texas
- Texas Tech University Health Sciences Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02938780
The ClinicalTrials.gov registry entry for NCT02938780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 686-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (55% lower). The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 2 interventions - of which placebo text message is the first listed.
NCT02938780 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02938780 about?
NCT02938780 is a clinical study titled "Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer Survivors". Preventing or reducing obesity is one factor that has been hailed as a way to improve quality of life, reduce recurrence, and increase survival rates among breast cancer survivors. An experienced team of multi-disciplinary researchers has developed an innovative and unique approach to encourage enha...
What is the current status of trial NCT02938780?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2015-06. Estimated completion is 2019-12.
What conditions does trial NCT02938780 study?
This clinical trial studies the following conditions: Breast Cancer Female.
What interventions are being tested in trial NCT02938780?
The interventions under investigation include: placebo text message (OTHER), nutrition physical activity text message (OTHER).
Who is sponsoring clinical trial NCT02938780?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02938780 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Cognitive Rehabilitation Following Breast Cancer Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.